Eko Analysis Software vs Viz AAA
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your practice requires an accessible, AI-powered solution for routine cardiovascular screening and early detection of common conditions like heart murmurs and atrial fibrillation at the point of care. This tool is ideal for clinicians seeking to augment their auscultation skills with AI insights, record and track heart sounds and ECGs, and facilitate telehealth consultations for ongoing patient monitoring.
View Eko Analysis Software →Choose Viz AAA if…
Choose Viz AAA if your hospital or emergency department needs an AI-driven solution to rapidly detect and prioritize suspected Abdominal Aortic Aneurysms from CT angiography scans. This tool is best suited for accelerating critical care pathways by providing real-time alerts and a secure communication platform to multidisciplinary teams, thereby improving time-sensitive treatment decisions for a life-threatening condition.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | Viz AAA |
|---|---|---|
| Pricing | Unknown | Enterprise (hospital/health system) |
| Deployment | Unknown | Cloud-based, integrates with PACS and EHR systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software integrates with digital stethoscopes and a mobile app, offering an intuitive experience for frontline clinicians at the point of care. Its design for mobile use with a familiar tool like the stethoscope lowers the barrier to adoption. While Viz AAA integrates well into hospital workflows, Eko's direct device interaction provides broader, more immediate usability for individual practitioners.
Clinical Value
TieBoth tools offer significant and FDA-cleared clinical value in their specialized areas. Eko Analysis Software provides AI-powered early detection of heart murmurs and AFib, with studies demonstrating improved detection rates for various cardiac conditions. Viz AAA is the first FDA-cleared AI for rapid detection and triage of suspected AAA, supported by studies showing high sensitivity and specificity.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software offers a transparent freemium model, allowing users to access basic features for free before subscribing for full AI capabilities. This approach provides flexibility and a clear understanding of costs upfront. In contrast, Viz AAA uses a subscription model with non-public pricing tiers, requiring direct engagement for cost information.
Enterprise Readiness
Viz AAAViz AAA is explicitly designed for seamless integration into existing hospital workflows, including EHR and PACS systems, and provides real-time alerts to multidisciplinary care teams. Its widespread deployment in over 2,000 hospitals and focus on care coordination demonstrate superior enterprise readiness. While Eko offers enterprise features and integrations, Viz AAA's core design and adoption are more geared towards complex health system environments.
Innovation
TieBoth tools represent significant innovation in their respective domains. Eko Analysis Software innovates by modernizing the traditional stethoscope with AI for early, non-invasive cardiac disease detection. Viz AAA is a pioneering solution, being the first FDA-cleared AI for AAA detection and triage from CTA scans, accelerating critical care pathways.
Support & Docs
Viz AAAViz AAA offers robust customer support, including 24/7/365 urgent phone support, email support, a comprehensive help center, and a knowledge base. This round-the-clock availability is crucial for a tool involved in time-sensitive, high-acuity clinical decisions. Eko provides email and scheduled phone support, along with a help center, but lacks the immediate, 24/7 phone support offered by Viz.ai.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | Viz AAA |
|---|---|---|
| Product Name | Eko Analysis Software | Viz AAA |
| Company | Eko Devices | Viz.ai |
| Core Function | AI-powered tool for early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, integrating with digital stethoscopes and a mobile app. | AI-powered solution for detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination. |
| Primary AI Detection Focus | Heart murmurs, atrial fibrillation (AFib), normal sinus rhythm | Suspected Abdominal Aortic Aneurysm (AAA) from CTA scans |
| Applicable Specialties | Cardiology, Emergency Medicine, Internal Medicine | Emergency Medicine, Radiology, Vascular Surgery |
| Key Workflow Integration | Integrates with Eko's digital stethoscopes and mobile app for wireless auscultation, recording, and visualization of heart sounds and ECGs. | Integrates into existing hospital workflows, provides real-time alerts to care teams, and includes a HIPAA-compliant communication platform. |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and Viz AAA.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Analysis Software or Viz AAA
Backers
Who funded each tool's parent company.